Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)
Phase 2
Withdrawn
- Conditions
- COVID-19 Acute Respiratory Distress SyndromeCOVID-19
- Interventions
- Other: Placebo
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- 4Living Biotech
- Registration Number
- NCT05411575
- Locations
- 🇧🇬
University Hospital for Active Treatment and Emergency Medicine NI Pirogov EAD, Sofia, Bulgaria
🇧🇬Multiprofile Hospital for Active Treatment AD Haskovo, Haskovo, Bulgaria
🇧🇬Military Medical Academy Multiprofile Hospital for Active Treatment Sofia, Sofia, Bulgaria
© Copyright 2025. All Rights Reserved by MedPath